REPL Stock Analysis: Buy, Sell, or Hold?
REPL - Replimune Group, Inc.
$11.42
0.24 (2.15%)
▲
5d:
+27.46%
30d:
+118.77%
90d:
+63.61%
WAIT
LOW Confidence
Analysis Updated: Jun 23, 2026 12:00 AM ET
Earnings: Jun 25, 2026
TODAY
Get Alerted When REPL Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
⏸️ WAIT FOR BETTER ENTRY: REPL is 12.6% above its trading range ($10.14). While momentum could continue, risk/reward favors waiting for a pullback.
⏸️ WAIT FOR BETTER ENTRY: REPL is 12.6% above its trading range ($10.14). While momentum could continue, risk/reward favors waiting for a pullback.
In-depth Analysis How we analyze
Valuation Analysis: REPL is currently trading at $11.42, which is considered extended relative to its 30-day fair value range of $5.61 to $10.14.
Technical Outlook: Technically, REPL is in a strong downtrend. Immediate support is located at $8.25, while resistance sits at $12.23.
Market Sentiment: REPL has a strong technical setup (60/100), with favorable trendlines, momentum, and price action for short-term traders. However, the stock is trading significantly above the average Wall Street target of $4.67. Current signals suggest waiting for a better entry point before initiating new positions.
Technical Outlook: Technically, REPL is in a strong downtrend. Immediate support is located at $8.25, while resistance sits at $12.23.
Market Sentiment: REPL has a strong technical setup (60/100), with favorable trendlines, momentum, and price action for short-term traders. However, the stock is trading significantly above the average Wall Street target of $4.67. Current signals suggest waiting for a better entry point before initiating new positions.
Quick Decision Summary
Current Position
EXTENDED
Historical Trading Range
$5.61 -
$10.14
Company Quality Score
63/100
(BUY)
Volume Confirmation
HIGH
Confidence Score
42.1%
Protect Your Profits
REPL is technically overbought (RSI 76). Consider hedging now to protect against a potential pullback while keeping your upside.
View Profit Protection PlanAll Signals
- BEARISH: Price significantly overextended (+12.6% above its trading range)
- BULLISH: Strong technical setup (60/100)
- BULLISH: High volume confirmation
- BEARISH: Trading 59.1% above Wall St target ($4.67)
Trading Range Analysis
30-Day Trading Range
$5.61 -
$10.14
Current vs Trading Range
EXTENDED
Support & Resistance Levels
Support Level
$8.25
Resistance Level
$12.23
Current Trend
Strong Downtrend
Technical data as of
Jun 23, 2026
Fundamental Context
Forward P/E (Next Year Est.)
-5.53
Wall Street Target
$4.67
(-59.1%)
Share & Embed Analysis
Last updated: June 23, 2026 8:05 PM ET
Data refreshes hourly during market hours. Next update: 9:05 PM
Data refreshes hourly during market hours. Next update: 9:05 PM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is REPL showing a specific setup today?
Insider Activity (6 Months)
0
Buys
1
Sells
Net
INSIDERS SELLING
Recent Transactions
Christopher Sarchi
SELL
6500 shares
2026-04-02
Top Rated Biotechnology Stocks
Top-rated stocks in Biotechnology by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
BMRN
Biomarin Pharmaceutical … |
STRONG BUY
29 analysts |
$88 | 65 BUY |
|
ALNY
Alnylam Pharmaceuticals … |
STRONG BUY
30 analysts |
$436 | 54 HOLD |
|
VRTX
Vertex Pharmaceuticals I… |
BUY
34 analysts |
$549 | 67 BUY |
|
CRSP
Crispr Therapeutics AG |
BUY
28 analysts |
$84 | 59 HOLD |
|
LEGN
Legend Biotech Corp |
STRONG BUY
22 analysts |
$58 | 52 HOLD |
Advanced REPL Option Strategies
Professional options setups generated by AI based on today's REPL price and gamma walls.
